AUP.TO
Aurinia Pharmaceuticals Inc
Price:  
16.76 
CAD
Volume:  
137,920.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AUP.TO WACC - Weighted Average Cost of Capital

The WACC of Aurinia Pharmaceuticals Inc (AUP.TO) is 5.3%.

The Cost of Equity of Aurinia Pharmaceuticals Inc (AUP.TO) is 5.60%.
The Cost of Debt of Aurinia Pharmaceuticals Inc (AUP.TO) is 5.00%.

Range Selected
Cost of equity 4.90% - 6.30% 5.60%
Tax rate 0.10% - 0.10% 0.10%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.0% - 5.6% 5.3%
WACC

AUP.TO WACC calculation

Category Low High
Long-term bond rate 3.4% 3.9%
Equity market risk premium 4.7% 5.7%
Adjusted beta 0.33 0.34
Additional risk adjustments 0.0% 0.5%
Cost of equity 4.90% 6.30%
Tax rate 0.10% 0.10%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.0% 5.6%
Selected WACC 5.3%